ArticleAdipocyte2026
β2-adrenergic receptor stimulation drives differentiation of human adipose-derived mesenchymal stem cells into beige adipocytes.
Article in Adipocyte, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-Adrenergic receptors (β-ARs) drive the induction of beige adipocytes in rodents and humans, yet the dominant human subtype, β2-AR or β3-AR, remains debated. This study aimed to confirm whether human adipose-derived mesenchymal stem cell (hADSCs)-derived adipocytes can serve as a beiging-competent model under human-relevant browning stimuli and to compare the involvement of β2-AR and β3-AR in hADSCs-derived beige adipocyte differentiation. hADSCs were differentiated into adipocytes using an adipogenic cocktail in the presence or absence of human-relevant browning stimuli or β2-AR/β3-AR-selective agonists with or without β2-AR/β3-AR-selective antagonists. Non-selective β-AR activation induces beige adipogenesis along with mRNA and/or protein expression of beiging markers, including uncoupling protein 1 (UCP1), appearance of multilocular adipocytes, and enhanced mitochondrial respiratory readouts. Moreover, norepinephrine, forskolin, and trigonelline increased mRNA and/or protein expression of UCP1. Pharmacological dissection with subtype-selective agonists and antagonists revealed that activation of β2-AR, but not β3-AR, is necessary and sufficient for inducing UCP1. The β2-AR blockade abolished UCP1 upregulation, whereas the β3-AR blockade had minimal effects. β2-selective stimulation recapitulated the beiging response. This study establishes hADSCs-derived adipocytes as a practicable, human-relevant platform for screening pharmacological agents and food-derived compounds and identifies β2-AR as a translationally actionable target for inducing beige adipocytes in humans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.